Therapeutic Action
Osmotic laxative
PDF page 187
Drug reference
Osmotic laxative
PDF page 187
Prevention of constipation in patients taking opioid analgesics (e.g. codeine, morphine)
PDF page 187
Do not administer to patients with Crohn’s disease, ulcerative colitis, intestinal obstruction, undiagnosed abdominal pain. May cause: abdominal discomfort, flatulence and diarrhoea. In the event of diarrhoea, exclude a faecal impaction and intestinal obstruction; reduce the dose. Pregnancy: no contra-indication Breast-feeding: no contra-indication
PDF page 187
10 g/15 ml oral solution, to be administered using a measuring device (oral syringe, measuring spoon, or cup with graduations)
PDF page 187
Child under 1 year: 5 ml daily (3.3 g daily) Child from 1 to 6 years: 5 to 10 ml daily (3.3 to 6.7 g daily) Child from 7 to 14 years: 10 to 15 ml daily (6.7 to 10 g daily) Child over 14 years and adult: 15 to 45 ml daily (10 to 30 g daily) Start lactulose when analgesic treatment continues more than 48 hours. Lactulose must be taken daily, until the end of the opioid treatment. Regular follow up (frequency/consistency of stools) is essential in order to adjust dosage correctly.
PDF page 187
It may take up to 48 hours, or even longer, before the treatment is effective. Lactulose is not indicated in acute constipation where a rapid result is needed. If necessary, lactulose may be given in combination with a stimulant laxative (e.g. bisacodyl, senna). The oral solution may be taken undiluted, or diluted in water. The treatment should be accompanied by dietary measures (fluids and fibre).
PDF page 187
Below 25 °C. Do not store in a refrigerator (cristallisation).
PDF page 188
5 ml daily (3.3 g daily)
PDF page 187
5 to 10 ml daily (3.3 to 6.7 g daily)
PDF page 187
10 to 15 ml daily (6.7 to 10 g daily)
PDF page 187
15 to 45 ml daily (10 to 30 g daily)
PDF page 187